A growing number of women in the U.S. are turning to heroin after first taking prescription opioid medication. This places them at greater risk for HIV and hepatitis C, and for spending time in the court system.
Scientists, however, have little insight into why this is happening. A University at Buffalo researcher, with colleagues from Columbia University and the University of Rochester, has received funding to provide some clues by working with a unique drug treatment court (DTC) in Buffalo.
Sarahmona Przybyla, PhD, an assistant professor of community health and health behavior in UB’s School of Public Health and Health Professions, was awarded $30,000 through the University of Rochester Center for AIDS Research (CFAR) for the 10-month project. Przybyla’s co-principal investigator is Diane Morse, MD, an infectious disease physician at the University of Rochester.
The script was flipped between the 1960s and early 2000s, according to federal data from the National Institute of...Read more